Literature DB >> 15863319

Synthesis of thiosemicarbazone and 4-thiazolidinone derivatives and their in vitro anti-Toxoplasma gondii activity.

Rômulo P Tenório1, Cristiane S Carvalho, Carla S Pessanha, José G de Lima, Antônio R de Faria, Antônio J Alves, Edésio J T de Melo, Alexandre J S Góes.   

Abstract

Thiosemicarbazone and 4-thiazolidinone derivatives were synthesized in one and two step, respectively, from thiosemicarbazide, in satisfactory yields. Then, the synthesized compounds were submitted to evaluation against host cells infected with Toxoplasma gondii. The present studies showed that thiosemicarbazones 2 and 4-thiazolidinone derivatives 3 were effective against intracellular T. gondii.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15863319     DOI: 10.1016/j.bmcl.2005.03.048

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  14 in total

1.  Trypanocidal and cytotoxic evaluation of synthesized thiosemicarbazones as potential drug leads against sleeping sickness.

Authors:  Bienvenu Glinma; Sika D S Kpoviessi; Fernand A Gbaguidi; Coco N Kapanda; Joanne Bero; Joëlle Quetin-Leclercq; Mansourou Moudachirou; Jacques Poupaert; Georges C Accrombessi; Emma W Gachomo; Lamine Baba-Moussa; Simeon O Kotchoni
Journal:  Mol Biol Rep       Date:  2014-01-10       Impact factor: 2.316

2.  Microwave assisted tandem reactions for the synthesis of 2-hydrazolyl-4-thiazolidinones.

Authors:  Cecilia Saiz; Chiara Pizzo; Eduardo Manta; Peter Wipf; S Graciela Mahler
Journal:  Tetrahedron Lett       Date:  2009-02-25       Impact factor: 2.415

3.  Substituted N-aminothioglycolurils containing thiosemicarbazone moiety and their cytotoxic activity in vitro.

Authors:  Galina A Gazieva; Lada V Anikina; Sergei A Pukhov; Tatyana B Karpova; Yulia V Nelyubina; Angelina N Kravchenko
Journal:  Mol Divers       Date:  2016-05-23       Impact factor: 2.943

4.  New 4-thiazolidinones of nicotinic acid with 2-Amino-6-methylbenzothiazole and their biological activity.

Authors:  Navin B Patel; Faiyazalam M Shaikh
Journal:  Sci Pharm       Date:  2010-10-24

5.  2-[(E)-(2,4-Dichloro-benzyl-idene)amino]-isoindoline-1,3-dione.

Authors:  Mohammad Asad; Chuan-Wei Oo; Hasnah Osman; Madhukar Hemamalini; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-06-18

Review 6.  Drugs in development for toxoplasmosis: advances, challenges, and current status.

Authors:  P Holland Alday; Joseph Stone Doggett
Journal:  Drug Des Devel Ther       Date:  2017-01-25       Impact factor: 4.162

7.  Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18.

Authors:  Diego Molina; Rodrigo Cossio-Pérez; Cristian Rocha-Roa; Lina Pedraza; Edwar Cortes; Alejandro Hernández; Jorge E Gómez-Marín
Journal:  BMC Genomics       Date:  2018-11-29       Impact factor: 3.969

8.  In Vitro Anti-Toxoplasma gondii and Antimicrobial Activity of Amides Derived from Cinnamic Acid.

Authors:  Graziela Rangel Silveira; Karoline Azerêdo Campelo; Gleice Rangel Silveira Lima; Lais Pessanha Carvalho; Solange Silva Samarão; Olney Vieira-da-Motta; Leda Mathias; Carlos Roberto Ribeiro Matos; Ivo José Curcino Vieira; Edesio José Tenório de Melo; Edmilson José Maria
Journal:  Molecules       Date:  2018-03-28       Impact factor: 4.411

9.  4-Arylthiosemicarbazide derivatives as a new class of tyrosinase inhibitors and anti-Toxoplasma gondii agents.

Authors:  Adrian Bekier; Lidia Węglińska; Agata Paneth; Piotr Paneth; Katarzyna Dzitko
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

10.  A Perspective on Thiazolidinone Scaffold Development as a New Therapeutic Strategy for Toxoplasmosis.

Authors:  Cristian Rocha-Roa; Diego Molina; Néstor Cardona
Journal:  Front Cell Infect Microbiol       Date:  2018-10-16       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.